$0.00
0.00%
Nasdaq, Mon, Nov 25 2024
ISIN
US6301041074
Symbol
NH

NantHealth, Inc. Stock price

$0.00
+0.00 0.00% 1M
-0.85 99.77% 6M
-0.43 99.53% YTD
-0.37 99.46% 1Y
-20.25 99.99% 3Y
-18.00 99.99% 5Y
-278.85 100.00% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.00 0.00%
ISIN
US6301041074
Symbol
NH
Industry

Key metrics

Market capitalization $50.00k
Enterprise Value $274.17m
P/E (TTM) P/E ratio 0.00
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.27
P/S ratio (TTM) P/S ratio 0.00
P/B ratio (TTM) P/B ratio 0.00
Revenue growth (TTM) Revenue growth -1.93%
Revenue (TTM) Revenue $64.27m
EBIT (operating result TTM) EBIT $-38.93m
Free Cash Flow (TTM) Free Cash Flow $-32.02m
Cash position $7.68m
EPS (TTM) EPS $-8.19
Short interest 1.88%
Show more

Is NantHealth, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

NantHealth, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast NantHealth, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast NantHealth, Inc.:

Buy
100%

Financial data from NantHealth, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '23
+/-
%
64 64
2% 2%
100%
- Direct Costs 29 29
11% 11%
45%
35 35
7% 7%
55%
- Selling and Administrative Expenses 40 40
10% 10%
63%
- Research and Development Expense 19 19
16% 16%
30%
-24 -24
30% 30%
-38%
- Depreciation and Amortization 15 15
5% 5%
23%
EBIT (Operating Income) EBIT -39 -39
22% 22%
-61%
Net Profit -70 -70
20% 20%
-109%

In millions USD.

Don't miss a Thing! We will send you all news about NantHealth, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NantHealth, Inc. Stock News

Neutral
Business Wire
3 months ago
WINTERVILLE, N.C.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), is pleased to announce the appointment of Scott Maratea as Chief Revenue Officer. Scott has spent the last three decades leading high performing teams, exceeding revenue targets, and growing client relationships with the nation's leading healthcare organizations. Prior to joining NantHealth, Scott served as the Chief Revenue ...
Neutral
Business Wire
6 months ago
WINTERVILLE, N.C.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), proudly announces that its Utilization Management Program has earned a 3-year reaccreditation from the National Committee for Quality Assurance (NCQA), validating the strength and quality of the NantHealth program. Earning NCQA Utilization Management Accreditation involves meeting six stringent NCQA standards focused on consu...

Company Profile

NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer in United States, the United Kingdom, Singapore, and Canada. Its solutions include empower treatment decisions; improve patient outcomes; validate treatment options; enable high-quality care; lower costs; ensure appropriate reimbursement; and streamline implementation and deployment. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Culver City, CA.

Head office United States
CEO R. Naseem
Founded 2010
Website www.nanthealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today